ADMA MEXC RealStocks
Own real ADMA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 14:21:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
ADMA Biologics, Inc. (ADMA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $13.27, with a market capitalization of $2.81B and a P/E ratio of 16.04. Over the past 52 weeks, its price has ranged from $7.21 to $20.46. This page covers its latest market performance, valuation, price trends and company information.
$2.81B | |
$13.09 | |
$13.27 | |
$13.09 | |
$13.19 | |
10.52K | |
3.10M | |
16.04 | |
$20.46 | |
$7.21 | |
-- | |
-- |
ADMA Biologics, Inc. (ADMA) is trading at $13.27 in pre-market trading as of 2026-11-12 14:17:00, up 0.57% ($0.08) from the previous close of $13.19
Pre-market trading shows how investors are pricing ADMA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, ADMA Biologics, Inc. (ADMA) moved from $11.11 to $13.27, representing a gain of 19.40% ($2.16).
The stock traded between $10.25 and $13.77 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 6.76 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 45.7%
ADMA is currently trading at $13.27, placing it 45.7% of the way from its 52-week low of $7.21 to its 52-week high of $20.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 647 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for ADMA Biologics, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of ADMA Biologics, Inc. (ADMA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ADMA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ADMA shares and USD.
ADMA Shares to USD
1.00 ADMA shares = 13.265 USD
Calculations are estimates based on the latest available price and are for reference only.